#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    B-cell small lymphocytic lymphoma refractory Ocular lymphoma High-grade B-cell lymphoma Chronic kidney disease Retinal dystrophy Fallopian tube cancer Glomerulonephritis minimal lesion Erdheim-Chester disease Follicular lymphoma Bronchopulmonary dysplasia Colon cancer Precursor T-lymphoblastic lymphoma/leukaemia recurrent Leukocyte adhesion deficiency type I Infective uveitis Eosinophilic oesophagitis More trials…

    Learn about Rare Diseases

    Choroid melanoma – Treatment Lysosomal storage disorder – Life with Disease Mucopolysaccharidosis III – Diagnostics Erdheim-Chester disease – Trials in Disease Osteosarcoma metastatic – Trials in Disease Progressive multifocal leukoencephalopathy Waldenstrom’s macroglobulinaemia recurrent – Trials in Disease Progressive supranuclear palsy Mantle cell lymphoma – Basic Information Langerhans cell sarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ephedrine Hydrochloride Iloprost Trometamol Senicapoc Imatinib Mesilate Vinorelbine Rifapentine Fipaxalparant Niraparib Tosilate Monohydrate Afimetoran Besilate Dihydrate NADOFARAGENE FIRADENOVEC FIBRIN Metoclopramide Haloperidol Decanoate Alxn1850 Vatiquinone Acetylsalicylic Acid Olodaterol Gliclazide NAVENIBART Dapansutrile More therapies…

    Learn about Your Condition

    Nocturia Thyroidectomy Blood iron increased Oedema peripheral Ocular melanoma Stem cell transplant Squamous cell carcinoma B-cell type acute leukaemia Skin neoplasm excision Biliary tract disorder Hepatotoxicity Peripheral ischaemia Femur fracture Athetosis Gastric cancer recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Diabetes mellitus

  • Sodium-glucose cotransporter-2 inhibitor drug combination for patients with diabetes and heart attack to slow coronary artery disease progression

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myocardial infarction
    • Diabetes mellitus
    Investigated Drugs:
    • Canagliflozin
    • Empagliflozin
    • Dapagliflozin
    Italy

  • A study of estradiol and progesterone treatment for blood sugar control in women with type 1 or type 2 diabetes during or after menopause

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Menopause
    • Diabetes mellitus
    Investigated Drugs:
    • Estradiol
    • Progesterone, Micronised
    The Netherlands

  • A Study of Teplizumab Compared to Placebo for Blood Sugar Control in Children and Young Adults Aged 1 to 25 Years with Newly Diagnosed Type 1 Diabetes

    Recruiting

    3 1
    Investigated Diseases:
    • Diabetes mellitus
    Investigated Drugs:
    • Teplizumab
    Belgium Czechia France Germany Greece Italy +4

  • Study of IMMUNOSTEM gene therapy using modified stem cells for newly diagnosed patients with type 1 diabetes who still produce insulin

    Recruiting

    2 1 1
    Investigated Drugs:
    • IMMUNOSTEM
    Italy

  • Study of Allopurinol to Reduce Cardiovascular Events in High-Risk Patients with Heart Disease and Long-COVID Syndrome

    Recruiting

    3 1 1
    Investigated Diseases:
    • Transient ischaemic attack
    • Atrial fibrillation
    • Ischaemic stroke
    Investigated Drugs:
    • Allopurinol
    Poland

  • Study on the Safety and Effectiveness of VX-880 for Patients with Type 1 Diabetes and Severe Low Blood Sugar Awareness

    Recruiting

    4 1 1
    Investigated Diseases:
    • Diabetes mellitus
    • Hypoglycaemia
    Investigated Drugs:
    • ZIMISLECEL
    France Germany Italy The Netherlands Norway
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!